Authors,Author(s) ID,Title,Year,Source tittle,Cited by,DOI,Country,Document Type,City,Access Type,aggregationType,EID
Creighton C.J.,,Comprehensivemolecular characterization of clear cell renal cell carcinoma,2013,Nature,1633,10.1038/nature12222,United States,Article,Houston,1,Journal,2-s2.0-84879890360
Lawrence M.S.,,Mutational heterogeneity in cancer and the search for new cancer-associated genes,2013,Nature,2675,10.1038/nature12213,United States,Article,Cambridge,0,Journal,2-s2.0-84880507665
Ley T.J.,,Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia,2013,New England Journal of Medicine,2323,10.1056/NEJMoa1301689,United States,Article,St. Louis,0,Journal,2-s2.0-84878372012
Vogelstein B.,,Cancer genome landscapes,2013,Science,3950,10.1126/science.1235122,United States,Review,Baltimore,1,Journal,2-s2.0-84875490185
Cibulskis K.,,Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples,2013,Nature Biotechnology,1959,10.1038/nbt.2514,United States,Article,Cambridge,1,Journal,2-s2.0-84874025843
Kapur P.,,Effects on survival of BAP1 and PBRM1 mutations in sporadic clear-cell renal-cell carcinoma: A retrospective analysis with independent validation,2013,The Lancet Oncology,252,10.1016/S1470-2045(12)70584-3,United States,Article,Dallas,0,Journal,2-s2.0-84873081430
Piazza R.,,Recurrent SETBP1 mutations in atypical chronic myeloid leukemia,2013,Nature Genetics,230,10.1038/ng.2495,Italy,Article,Milan,0,Journal,2-s2.0-84871988651
Getz G.,,Integrated genomic characterization of endometrial carcinoma,2013,Nature,1900,10.1038/nature12113,United States,Article,Cambridge,1,Journal,2-s2.0-84877254190
Myung J.,,IDH1 mutation of gliomas with long-term survival analysis,2012,Oncology Reports,26,10.3892/or.2012.1994,South Korea,Article,Seoul,1,Journal,2-s2.0-84866443042
Koboldt D.C.,,Comprehensive molecular portraits of human breast tumours,2012,Nature,6015,10.1038/nature11412,United States,Article,St. Louis,1,Journal,2-s2.0-84877028141
Dees N.,,MuSiC: Identifying mutational significance in cancer genomes,2012,Genome Research,369,10.1101/gr.134635.111,United States,Article,St. Louis,1,Journal,2-s2.0-84864598664
Welch J.S.,,The origin and evolution of mutations in acute myeloid leukemia,2012,Cell,926,10.1016/j.cell.2012.06.023,United States;United States,Article,St. Louis;St. Louis,1,Journal,2-s2.0-84864255882
Muzny D.M.,,Comprehensive molecular characterization of human colon and rectal cancer,2012,Nature,4331,10.1038/nature11252,United States,Article,Houston,1,Journal,2-s2.0-84863922124
Peña-Llopis S.,,BAP1 loss defines a new class of renal cell carcinoma,2012,Nature Genetics,504,10.1038/ng.2323,United States;United States;United States,Article,Dallas;Dallas;Richardson,0,Journal,2-s2.0-84862988411
Ellis M.J.,,Whole-genome analysis informs breast cancer response to aromatase inhibition,2012,Nature,712,10.1038/nature11143,United States;United States,Article,St. Louis;St. Louis,1,Journal,2-s2.0-84862584058
Downing J.R.,,The pediatric cancer genome project,2012,Nature Genetics,174,10.1038/ng.2287,United States,Review,"Memphis TN,",0,Journal,2-s2.0-84861633881
Roth A.,,JointSNVMix: A probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data,2012,Bioinformatics,116,10.1093/bioinformatics/bts053,Canada,Article,Vancouver,1,Journal,2-s2.0-84859249611
Koboldt D.,,VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing,2012,Genome Research,2008,10.1101/gr.129684.111,United States,Article,St. Louis,1,Journal,2-s2.0-84863229597
Vandin F.,,De novo discovery of mutated driver pathways in cancer,2012,Genome Research,248,10.1101/gr.120477.111,United States,Article,Providence,1,Journal,2-s2.0-84856532705
Larson D.,,Somaticsniper: Identification of somatic point mutations in whole genome sequencing data,2012,Bioinformatics,305,10.1093/bioinformatics/btr665,United States,Article,St Louis,1,Journal,2-s2.0-84856565531
Ding L.,,Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing,2012,Nature,1257,10.1038/nature10738,United States,Article,St. Louis,1,Journal,2-s2.0-84862776906
Bolton K.L.,,Association between BRCA1 and BRCA2 Mutations and Survival in Women with Invasive Epithelial Ovarian Cancer,2012,JAMA - Journal of the American Medical Association,362,10.1001/jama.2012.20,United States;United States,Article,Bethesda;Los Angeles,1,Journal,2-s2.0-84856158117
Jiao Y.,,"Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas",2012,Oncotarget,380,10.18632/oncotarget.588,United States,Article,Baltimore,1,Journal,2-s2.0-84868625787
Yang D.,,"Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer",2011,JAMA - Journal of the American Medical Association,326,10.1001/jama.2011.1456,United States,Article,Houston,1,Journal,2-s2.0-80053950209
Ma Z.,,Bayesian estimation of beta mixture models with variational inference,2011,IEEE Transactions on Pattern Analysis and Machine Intelligence,130,10.1109/TPAMI.2011.63,Sweden,Article,Stockholm,0,Journal,2-s2.0-80053127168
Bell D.,,Integrated genomic analyses of ovarian carcinoma,2011,Nature,4070,10.1038/nature10166,United States,Article,Rochester,1,Journal,2-s2.0-79959838081
Varela I.,,Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma,2011,Nature,858,10.1038/nature09639,United Kingdom,Article,Hinxton,0,Journal,2-s2.0-79251635938
Ley T.J.,,DNMT3A mutations in acute myeloid leukemia,2010,New England Journal of Medicine,1298,10.1056/NEJMoa1005143,United States;United States,Article,St. Louis;St. Louis,0,Journal,2-s2.0-78649906060
Etcheverry A.,,DNA methylation in glioblastoma: Impact on gene expression and clinical outcome,2010,BMC Genomics,123,10.1186/1471-2164-11-701,France;France;France,Article,Rennes;Rennes;Rennes,1,Journal,2-s2.0-78650035002
Tao M.,,DNA methylation in endometrial cancer,2010,Epigenetics,57,10.4161/epi.5.6.12431,United States,Review,Buffalo,1,Journal,2-s2.0-77957365492
Clapier C.R.,,The biology of chromatin remodeling complexes,2009,Annual Review of Biochemistry,1270,10.1146/annurev.biochem.77.062706.153223,United States,Review,Salt Lake City,0,Book Series,2-s2.0-67650725820
Ding L.,,Somatic mutations affect key pathways in lung adenocarcinoma,2008,Nature,1868,10.1038/nature07423,United States,Article,St. Louis,1,Journal,2-s2.0-54549094903
McLendon R.,,Comprehensive genomic characterization defines human glioblastoma genes and core pathways,2008,Nature,4803,10.1038/nature07385,United States,Article,Durham,1,Journal,2-s2.0-54549108740
Jones S.,,Core signaling pathways in human pancreatic cancers revealed by global genomic analyses,2008,Science,2700,10.1126/science.1164368,United States,Article,Baltimore,0,Journal,2-s2.0-52149123619
Parsons D.,,An integrated genomic analysis of human glioblastoma multiforme,2008,Science,3876,10.1126/science.1164382,United States;United States,Article,Baltimore;Houston,0,Journal,2-s2.0-52949127312
Wood L.D.,,The genomic landscapes of human breast and colorectal cancers,2007,Science,2344,10.1126/science.1145720,United States,Article,Baltimore,0,Journal,2-s2.0-36248962105
Sjöblom T.,,The consensus coding sequences of human breast and colorectal cancers,2006,Science,2602,10.1126/science.1133427,United States,Article,Baltimore,0,Journal,2-s2.0-33749993417
Hanahan D.,,The hallmarks of cancer,2000,Cell,19621,10.1016/S0092-8674(00)81683-9,United States,Review,San Francisco,1,Journal,2-s2.0-0034614637
